Archive | Medical News RSS feed for this section

De Gea undergoing Man Utd medical – World Soccer

27. June 2011

0 Comments

De Gea undergoing Man Utd medical
World Soccer
David de Gea has arrived in England and is undergoing a medical ahead of his proposed move to Manchester United. The Spanish goalkeeper has been identified by Sir Alex Ferguson as the long-term successor to Edwin van der Sar at Old Trafford.

and more »

More:
De Gea undergoing Man Utd medical – World Soccer

Continue reading...

Intensive Therapy Yields Small Benefits in Type 2 Diabetes – Medscape

25. June 2011

0 Comments

Intensive Therapy Yields Small Benefits in Type 2 Diabetes
Medscape
Hopefully we will see an increasing difference between the 2 groups," he told Medscape Medical News at the conference. "One thing that strikes me about this study is how well the routine care group were treated," said Sue Kirkman, MD,

and more »

Read the original:
Intensive Therapy Yields Small Benefits in Type 2 Diabetes – Medscape

Continue reading...

ReCell ‘skin’ widens introduction – ModernMedicine

24. June 2011

0 Comments

ReCell 'skin' widens introduction
ModernMedicine
Cambridge, England — Regenerative medicine firm Avita Medical, based here, introduced its ReCell Spray-On-Skin at a symposium held at the recent Cosmedica 2011 Congress for Aesthetic & Surgical Medicine held in Bochum, Germany, Medical News Today

and more »

See the article here:
ReCell ‘skin’ widens introduction – ModernMedicine

Continue reading...

Avita hosts ReCell symposium – ModernMedicine

22. June 2011

0 Comments

Avita hosts ReCell symposium
ModernMedicine
Cambridge, England — Regenerative medicine firm Avita Medical, based here, introduced its ReCell Spray-On-Skin at a symposium held at the recent Cosmedica 2011 Congress for Aesthetic & Surgical Medicine held in Bochum, Germany, Medical News Today

Originally posted here:
Avita hosts ReCell symposium – ModernMedicine

Continue reading...

Jury Out on Early Intervention for Psychosis – Medscape

17. June 2011

0 Comments

Jury Out on Early Intervention for Psychosis
Medscape
and it needs to be replicated urgently, ideally in a very large sample," Oliver Freudenreich, MD, who was not involved in the Cochrane review, told Medscape Medical News. He is director of the First Episode and Early Psychosis Program at Massachusetts

See more here:
Jury Out on Early Intervention for Psychosis – Medscape

Continue reading...

Prostate Cancer Kills Half Those Diagnosed in UK, But Not US – Medscape

17. June 2011

0 Comments

Prostate Cancer Kills Half Those Diagnosed in UK, But Not US
Medscape
"I would rather have the potential — and I emphasize the potential — for overtreating than swing the other way and lose all of these patients to a disease that is curable," Dr. Thrasher explained in an interview with Medscape Medical News.

and more »

Visit link:
Prostate Cancer Kills Half Those Diagnosed in UK, But Not US – Medscape

Continue reading...

Acute Myeloid Leukemia Patients Overdosed With Cytarabine – Medscape

16. June 2011

0 Comments

Acute Myeloid Leukemia Patients Overdosed With Cytarabine
Medscape
The group recently published these findings in the New England Journal of Medicine (2011;364:1027-1036), as reported at the time by Medscape Medical News. Over the years, doses of cytarabine have ranged from 100 to 3000 mg/m 2 ; doses of 1000 mg/m 2

Read this article:
Acute Myeloid Leukemia Patients Overdosed With Cytarabine – Medscape

Continue reading...

Blinatumomab Produced Complete Remission in ALL – Medscape

15. June 2011

0 Comments

Blinatumomab Produced Complete Remission in ALL
Medscape
We are testing it in the most aggressive B-cell malignancy we know," he told Medscape Medical News in an interview. The primary end point of the single-group, multicenter, exploratory phase 2 trial was the rate of CR or CR+. Secondary end points were

Go here to see the original:
Blinatumomab Produced Complete Remission in ALL – Medscape

Continue reading...

Navitoclax Activity in Heavily Pretreated CLL – Medscape

14. June 2011

0 Comments

Navitoclax Activity in Heavily Pretreated CLL
Medscape
"I think the most impressive aspects are that navitoclax is a well-tolerated drug, and it has activity despite these patients having adverse prognostic indicators," he told Medscape Medical News. Dr. Seymour presented the results here at the 16th

Read more here:
Navitoclax Activity in Heavily Pretreated CLL – Medscape

Continue reading...

High-Dose Melphalan Preferable in Multiple Myeloma – Medscape

13. June 2011

0 Comments

High-Dose Melphalan Preferable in Multiple Myeloma
Medscape
In fact, in our study, progression-free survival was superior in patients who received high-dose melphalan plus ASCT," Dr. Palumbo told Medscape Medical News. All 402 of the patients in the study received induction therapy consisting of four 28-day

See the rest here:
High-Dose Melphalan Preferable in Multiple Myeloma – Medscape

Continue reading...